Planisware freut sich, auf der 29th Edition Strategic Project & Portfolio Management for Pharma von Marcus Evans Ende Januar vertreten zu sein. Unser Vortrag zeigt, wie künstliche Intelligenz strategische Zielsetzung, Portfoliosteuerung und operative Ausführung in pharmazeutischen Projekten wirkungsvoll miteinander verbindet.
Nachfolgend finden Sie die vollständige englische Vortragsbeschreibung:
From Vision to Value: How AI Can Contribute to Business Strategic Alignment in Pharmaceutical Projects
- Bridging Strategic Objectives with Execution KPIs
- Bird’s-Eye View Optimization (Resources, Schedule, Cost, Performance…)
- Powered by AI
In today’s fast‑changing business landscape, success depends on more than just delivering projects, it requires ensuring every initiative drives strategic priorities and measurable value. Artificial Intelligence is emerging as a game‑changer in this process, offering the insights and foresight needed to evaluate, prioritize, and manage portfolios with unprecedented accuracy and efficiency. This session will explore how AI strengthens the connection between strategic alignment and portfolio impact. Participants will learn how AI‑driven analytics can enhance decision‑making, optimize resource allocation, and identify initiatives that deliver the greatest organizational value. We’ll also share best practices for integrating AI into portfolio management frameworks and discuss why human collaboration remains essential for turning data‑driven insights into meaningful results.
Vincent Hunckler
Senior Project Manager, Planisware
Ahmed Ait Sidi Momma
Account Manager, Planisware
Weitere Informationen und Registrierung:
https://lnkd.in/dDbYeW-W